Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Chu

Showing results (111-120 of 211) with videos related to

Pageof 22
Sort By:
Biochemical and Biophysical Research Communications|November 30, 2007
Identification of a cis-acting element of human dihydrofolate reductase mRNANingwen Tai, John C Schmitz, Tian-Min Chen, et al.
Clinical Genitourinary Cancer|July 31, 2016
Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Practical Clinical Implications of Pharmacologic FeaturesRahul A Parikh, Leonard J Appleman, Jan H Beumer, et al.
Cancer Chemotherapy and Pharmacology|November 24, 2016
Phase I trial of daily triapine in combination with cisplatin chemotherapy for advanced-stage malignanciesCharles A Kunos, Edward Chu, Jan H Beumer, et al.
Acta Pharmaceutica Sinica. B|July 31, 2023
Emerging roles of Aurora-A kinase in cancer therapy resistanceDayong Zheng, Jun Li, Han Yan, et al.
Investigational New Drugs|March 4, 2005
A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancerJohn Murren, Manuel Modiano, Shivaani Kummar, et al.
Frontiers in Oncology|April 20, 2017
Phase I Trial of Triapine-Cisplatin-Paclitaxel Chemotherapy for Advanced Stage or Metastatic Solid Tumor CancersCharles A Kunos, Edward Chu, Della Makower, et al.
Transcultural Psychiatry|July 7, 2010
Ethno-cultural variations in the experience and meaning of mental illness and treatment: implications for access and utilizationElizabeth Carpenter-Song, Edward Chu, Robert E Drake, et al.
Nucleic Acids Research|March 2, 2013
Development of modified siRNA molecules incorporating 5-fluoro-2'-deoxyuridine residues to enhance cytotoxicityShao-yu Wu, Tian-min Chen, William H Gmeiner, et al.
Cell Communication and Signaling : CCS|February 21, 2018
Herbal formula Huang Qin Ge Gen Tang enhances 5-fluorouracil antitumor activity through modulation of the E2F1/TS pathwayHaizhou Liu, Hui Liu, Zhiyi Zhou, et al.
Archives of Surgery (Chicago, Ill. : 1960)|March 23, 2011
Cessation of clopidogrel before major abdominal proceduresArtur Chernoguz, Dana A Telem, Edward Chu, et al.
Pageof 22

Showing results (111-120 of 211) with videos related to

Sort By:
Pageof 22
Biochemical and Biophysical Research Communications|November 30, 2007
Identification of a cis-acting element of human dihydrofolate reductase mRNANingwen Tai, John C Schmitz, Tian-Min Chen, et al.
Clinical Genitourinary Cancer|July 31, 2016
Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Practical Clinical Implications of Pharmacologic FeaturesRahul A Parikh, Leonard J Appleman, Jan H Beumer, et al.
Cancer Chemotherapy and Pharmacology|November 24, 2016
Phase I trial of daily triapine in combination with cisplatin chemotherapy for advanced-stage malignanciesCharles A Kunos, Edward Chu, Jan H Beumer, et al.
Acta Pharmaceutica Sinica. B|July 31, 2023
Emerging roles of Aurora-A kinase in cancer therapy resistanceDayong Zheng, Jun Li, Han Yan, et al.
Investigational New Drugs|March 4, 2005
A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancerJohn Murren, Manuel Modiano, Shivaani Kummar, et al.
Frontiers in Oncology|April 20, 2017
Phase I Trial of Triapine-Cisplatin-Paclitaxel Chemotherapy for Advanced Stage or Metastatic Solid Tumor CancersCharles A Kunos, Edward Chu, Della Makower, et al.
Transcultural Psychiatry|July 7, 2010
Ethno-cultural variations in the experience and meaning of mental illness and treatment: implications for access and utilizationElizabeth Carpenter-Song, Edward Chu, Robert E Drake, et al.
Nucleic Acids Research|March 2, 2013
Development of modified siRNA molecules incorporating 5-fluoro-2'-deoxyuridine residues to enhance cytotoxicityShao-yu Wu, Tian-min Chen, William H Gmeiner, et al.
Cell Communication and Signaling : CCS|February 21, 2018
Herbal formula Huang Qin Ge Gen Tang enhances 5-fluorouracil antitumor activity through modulation of the E2F1/TS pathwayHaizhou Liu, Hui Liu, Zhiyi Zhou, et al.
Archives of Surgery (Chicago, Ill. : 1960)|March 23, 2011
Cessation of clopidogrel before major abdominal proceduresArtur Chernoguz, Dana A Telem, Edward Chu, et al.
Pageof 22